EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Detecting the FLJ22447 lncRNA in Ovarian Cancer with Cyclopentane-Modified FIT-PNAs (cpFIT-PNAs)

Sheethal Thomas Mannully iD, Rawan Mahajna, Huda Nazzal, Salam Maree, Hongchao Zheng iD, Daniel H Appella iD, Reuven Reich iD, Eylon Yavin

Biomolecules · 2024

DOI: 10.3390/biom14060609 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Sheethal Thomas Mannully und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Hadassah Ein-Kerem, Jerusalem 91120, Israel. Hauptthemen laut MEDLINE: Ovarian Neoplasms, RNA, Long Noncoding, Peptide Nucleic Acids, Cyclopentanes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Cancer Research Fund, Israel Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer (OC) is one of the most lethal gynecologic cancers that is typically diagnosed at the very late stage of disease progression. Thus, there is an unmet need to develop diagnostic probes for early detection of OC. One approach may rely on RNA as a molecular biomarker. In this regard, FLJ22447 lncRNA is an RNA biomarker that is over-expressed in ovarian cancer (OC) and in cancer-associated fibroblasts (CAFs). CAFs appear early on in OC as they provide a metastatic niche for OC progression. FIT-PNAs (forced intercalation-peptide nucleic acids) are DNA analogs that are designed to fluoresce upon hybridization to their complementary RNA target sequence. In recent studies, we have shown that the introduction of cyclopentane PNAs into FIT-PNAs (cpFIT-PNA) results in superior RNA sensors. Herein, we report the design and synthesis of cpFIT-PNAs for the detection of this RNA biomarker in living OC cells (OVCAR8) and in CAFs. cpFIT-PNA was compared to FIT-PNA and the cell-penetrating peptide (CPP) of choice was either a simple one (four L-lysines) or a CPP with enhanced cellular uptake (CLIP6). The combination of CLIP6 with cpFIT-PNA resulted in a superior sensing of FLJ22447 lncRNA in OVCAR8 cells as well as in CAFs. Moreover, incubation of CLIP6-cpFIT-PNA in OVCAR8 cells leads to a significant decrease (ca. 60%) in FLJ22447 lncRNA levels and in cell viability, highlighting the potential theranostic use of such molecules.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsRNA, Long NoncodingPeptide Nucleic AcidsCyclopentanesHumansFemaleCell Line, TumorBiomarkers, Tumor

Stichwörter der Autor:innen

FLJ22447 lncRNARNA biomarkercancer-associated fibroblastscell-penetrating peptidecyclopentane modified FIT-PNAovarian cancer

Substanzen

RNA, Long NoncodingPeptide Nucleic AcidsCyclopentanesBiomarkers, Tumor

Autor:innen und Institutionen

  • Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Hadassah Ein-Kerem, Jerusalem 91120, Israel.
  • Synthetic Bioactive Molecules Section, Laboratory of Bioorganic Chemistry (LBC), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, 8 Center Drive, Room 404, Bethesd…

ORCID-Profile: Sheethal Thomas Mannully, Hongchao Zheng, Daniel H Appella, Reuven Reich

Förderung

  • Israel Cancer Research Fund
  • Israel Science Foundation

Zitieren

APA

Mannully, S. T., Mahajna, R., Nazzal, H., Maree, S., Zheng, H., Appella, D. H., Reich, R., & Yavin, E. (2024). Detecting the FLJ22447 lncRNA in Ovarian Cancer with Cyclopentane-Modified FIT-PNAs (cpFIT-PNAs). Biomolecules. https://doi.org/10.3390/biom14060609

Vancouver

Mannully ST, Mahajna R, Nazzal H, Maree S, Zheng H, Appella DH, et al. Detecting the FLJ22447 lncRNA in Ovarian Cancer with Cyclopentane-Modified FIT-PNAs (cpFIT-PNAs). Biomolecules. 2024. doi:10.3390/biom14060609

BibTeX
@article{Mannully2024,
  author = {Mannully, Sheethal Thomas and Mahajna, Rawan and Nazzal, Huda and Maree, Salam and Zheng, Hongchao and Appella, Daniel H and Reich, Reuven and Yavin, Eylon},
  title = {Detecting the FLJ22447 lncRNA in Ovarian Cancer with Cyclopentane-Modified FIT-PNAs (cpFIT-PNAs)},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14060609}
}
Kostenlos starten →